Robert Iannone - Jun 5, 2021 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
EVP R&D, Chief Medical Officer
Signature
By: /s/Adam Guttmann, as attorney in fact For: Robert Iannone
Stock symbol
JAZZ
Transactions as of
Jun 5, 2021
Transactions value $
-$212,823
Form type
4
Date filed
6/9/2021, 06:57 PM
Next filing
Jun 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Tax liability -$213K -1.21K -3.98% $176.47 29.1K Jun 5, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
F2 Includes 147 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 28, 2021.